As returns on market increase, returns on owning Novartis are expected to decrease at a much smaller rate. During bear market, Novartis is likely to outperform the market.
Ulrich Lehner Vice Chairman of the Board of Directors, Non-Executive Director, MBA
Mark Fishman Member of the Executive Committee and President of Novartis Institute for BioMedical Research (NIBR), Ph.D
Novartis Price and Market Media
The median price of Novartis for the period between Tue, Apr 23, 2013 and Thu, May 23, 2013 is 73.9 with a coefficient of variation of 1.18. The daily time series for the period is distributed with a sample standard deviation of 0.87, arithmetic mean of 73.87, and mean deviation of 0.67. The Stock did not receive any noticable media coverage during the period.
Novartis AG [NVSEF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Mega-Cap' category with current market capitalization of 124.39 B. Novartis AG has 2.42 B outstanding shares.
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory